TB-500: The Other Half of the Healing Stack

If BPC-157 is the peptide people reach for when something hurts, TB-500 is the one they reach for when the whole system feels beat up. Muscle strains that radiate, nagging tendons that travel, a body that hasn't really rebuilt since last season. TB-500 doesn't feel local. It feels systemic — and that's by design.

This is the community take: what people actually run, how it pairs, and where the story gets thin.

What it is, in one paragraph

TB-500 is the research-peptide name for synthetic Thymosin Beta-4, a 43-amino-acid protein that exists in basically every cell in your body. Its day job is actin sequestration — it grabs free actin monomers and lets the cell remodel its skeleton quickly, which is exactly what healing tissue needs to do. It's also anti-inflammatory, pro-angiogenic (new blood vessel formation), and has a surprisingly deep human clinical trial history for things like corneal healing and pressure ulcers.

Dosing: what people actually do

TB-500 dosing runs on a loading + maintenance model, not daily. The half-life is only a couple of hours, but the downstream signaling persists for days, so nobody dumps it into daily injections.

• Loading phase: 2–2.5 mg, twice per week, for the first 4 weeks
• Maintenance: 2–2.5 mg, once per week, for another 4–8 weeks
• Site: Sub-Q, abdomen is the default. TB-500 is considered systemically active — the injection site doesn't seem to matter the way it sometimes does with BPC
• Cycle length: 8–12 weeks, then 4–6 weeks off before repeating

"First four weeks on the loading dose felt like nothing. Week six I realized I'd stopped thinking about my shoulder. That's TB-500 in a sentence." — forum user

Reconstitution math (5 mg vial)

Water added	Concentration	2.5 mg dose
2.0 mL BAC	2.5 mg/mL	100 units (full syringe)
2.5 mL BAC	2.0 mg/mL	125 units (over one syringe)

Most people mix a 5 mg vial with 2.0 mL and call it two doses. Clean, simple, no math at 4 AM.

What it pairs with

The famous pairing is BPC-157 + TB-500 — the healing stack. The mechanistic story is that BPC handles local repair signaling (nitric oxide, growth factors) while TB-500 handles cell migration and systemic recovery. Most serious injury protocols run both at full dose.

Also commonly stacked with:

• GHK-Cu when skin, hair, or connective tissue is the focus
• IGF-1 LR3 for muscle rebuild after a layoff
• A GHRH/GHRP stack (CJC/Ipa) when general recovery capacity is the goal, not a specific injury

Red flags and side effects

Community-reported stuff is mild:

• Mild lethargy or a "heavy" feeling in the first week of loading — usually passes
• Occasional head fog at the higher doses
• Injection site reactions are rare but happen

The theoretical concern that gets raised is tumor risk — TB-500 promotes cell migration and angiogenesis, which are things tumors also want. The literature is mixed and nothing has been clearly demonstrated in humans, but it's the one footnote honest discussions always include. If you have a cancer history, this is a conversation for an actual doctor, not a forum.

TB-500 is also on the WADA prohibited list. If you compete, you already know.

The honest limits

• Human trials exist (eye drops, wound gels) but none at the injectable systemic doses the research community uses. The dosing people run is extrapolated from rodent work
• It's expensive. 5 mg vials at 2.5 mg twice weekly burns through product fast
• The "TB-500" label in the wild can mean anything from full Tβ4 to just the LKKTETQ fragment. A COA matters

Where to go next

• For the full mechanism, sequence, and clinical trial landscape, see the Pepperpedia TB-500 entry
• For healing-stack protocols people are running right now, Protocol Discussions is where the real threads are
• Pair this with the BPC-157 field guide if you're building an injury protocol from scratch